Skip to main content
. 2018 Apr 28;218(6):946–955. doi: 10.1093/infdis/jiy223

Figure 4.

Figure 4.

Countrywide prevalence of known drug-resistance mutations in infected individuals. Mutations are color-coded by gene showing the proportion of infections carrying known resistance-associated mutations. No known artemisinin-resistance mutations were observed.